Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Early Breast Cancer
100%
Response Predictors
100%
Chromosome 11q
100%
Anthracycline-based Chemotherapy
100%
Node-negative Breast Cancer
100%
Chemotherapy
50%
Bacterial Artificial Chromosome
50%
Hormone Receptor-positive
50%
11q Deletion
50%
After Surgery
25%
Tumor
25%
Therapeutic Potential
25%
Clinical Outcomes
25%
Disease-free Survival
25%
Cox Proportional Hazards Model
25%
Randomized Clinical Trial
25%
Adjustment Method
25%
Recurrence Risk
25%
Genomic Data
25%
Clinical Genetics
25%
Genomic Signature
25%
Genomic Changes
25%
Relapsed Disease
25%
Genetic Features
25%
Biological Markers
25%
DNA Copy number Aberrations
25%
Lymph Node-positive Breast Cancer
25%
Cancer Genome
25%
Multiple Testing Adjustment
25%
Risk Response
25%
Adverse Influence
25%
Chemotherapy Response
25%
Adjuvant Systemic Therapy
25%
Model-based Testing
25%
Genomic Predictors
25%
Clinicopathologic Data
25%
Pathologic Features
25%
DNA Copy number Alterations
25%
Medicine and Dentistry
Breast Cancer
100%
Chromosome 11q
100%
Anthracycline
100%
Chemotherapy
100%
Genetics
66%
Gene Dosage
33%
Bacterial Artificial Chromosome
33%
Recurrent Disease
16%
Receptor
16%
Proportional Hazards Model
16%
Tamoxifen
16%
Adjuvant Therapy
16%
Disease Free Survival
16%
Lymph Node
16%
Recurrence Risk
16%
Hormone Receptor
16%
Genomic Signature
16%
Biological Marker
16%
Tumor
16%
Randomized Clinical Trials
16%
Neuroscience
Chromosome 11q
100%
Anthracycline
100%
Chemotherapy
100%
Genetics
66%
Gene Dosage
33%
Bacterial Artificial Chromosome
33%
Lymph Node
16%
Hormone Receptor
16%
Adjuvant Therapy
16%
Genomic Signature
16%
Receptor
16%
Tamoxifen
16%
Biological Marker
16%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Chemotherapy Regimens
100%
Anthracycline
100%
Receptor
16%
Recurrent Disease
16%
Disease Free Survival
16%
Tamoxifen
16%
Biological Marker
16%
Recurrence Risk
16%
Randomized Clinical Trial
16%
Hormone Receptor
16%